Nearly One in Three Women in Their 20s Have Never Had a Cervical Screening

A recent study reveals alarming trends in cervical cancer screening among young women, with nearly one-third of women aged 21 to 29 reporting they have never undergone screening. This figure, which stands at 31.9% for 2023, has significantly increased from just 12.5% in 2005. The findings were published in JAMA Network Open and raise concerns regarding awareness and access to preventive health measures.

The research highlighted disparities in screening rates based on various factors, including race, education level, insurance status, and geographic location. For instance, Asian women were found to have the highest prevalence of never being screened in both the younger and older age groups studied. Additionally, uninsured women aged 30 to 65 are more likely to have never been screened for cervical cancer.

Cervical cancer is largely preventable through the human papillomavirus (HPV) vaccination and regular screenings, which can detect precancerous changes before they develop into cancer. Despite these preventive measures, cervical cancer screening rates have not rebounded to pre-pandemic levels, unlike screenings for other types of cancer such as breast and colorectal cancer.

The study utilized data from the National Health Interview Survey, which included a cervical cancer screening questionnaire. Researchers adjusted their estimates to account for women who had undergone hysterectomies, allowing for a clearer picture of screening rates among the target age groups.

Experts note that the decline in screening rates may be attributed to several barriers. These include costs, lack of insurance, transportation issues, misinformation about HPV vaccination, discomfort related to the screening process, and general unawareness of the necessity for such screenings. Dr. Sherry Ross, a board-certified OB/GYN, suggests that confusion surrounding guidelines for Pap smears, HPV vaccination access, and healthcare availability contributes to the low screening rates.

Moreover, the incidence of regional- and distant-stage cervical cancer has risen by more than 2% annually since 2017 among women aged 30 to 64. This trend underscores the importance of regular screenings, which can detect abnormalities early when they are more easily treatable.

Cervical cancer screenings typically involve a Pap test, an HPV test, or a combination of both. The American Cancer Society recommends that individuals at average risk begin regular screenings at age 25 and continue until at least age 65. These screenings are crucial even for those who have received the HPV vaccine, as the vaccine does not eliminate the risk of cervical cancer.

Healthcare providers encourage women to discuss their personal risk factors and screening schedules with their doctors to ensure they receive appropriate care. Regular screenings can be lifesaving, detecting not only cancer but also precancerous conditions that can be effectively managed.